Phase II trial of Remitogen (humanized 1D10) monoclonal antibody targeting class II in patients with relapsed low-grade or follicular lymphoma
- PMID: 11779298
- DOI: 10.3816/clm.2001.n.026
Phase II trial of Remitogen (humanized 1D10) monoclonal antibody targeting class II in patients with relapsed low-grade or follicular lymphoma
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources